The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life.

MLA

Bagnasco, Diego, et al. “The Importance of Being Not Significant: Blood Eosinophils and Clinical Responses Do Not Correlate in Severe Asthma Patients Treated with Mepolizumab in Real Life.” Allergy, vol. 75, no. 6, June 2020, pp. 1460–63. EBSCOhost, https://doi.org/10.1111/all.14135.

APA

Bagnasco, D., Massolo, A., Bonavia, M., Brussino, L., Bucca, C., Caminati, M., Canonica, G. W., Caruso, C., D’Amato, M., De Ferrari, L., Guida, G., Heffler, E., Lombardi, C., Menzella, F., Milanese, M., Paoletti, G., Riccio, A. M., Rolla, G., Senna, G., … Passalacqua, G. (2020). The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life. Allergy, 75(6), 1460–1463. https://doi.org/10.1111/all.14135

Chicago

Bagnasco, Diego, Alessandro Massolo, Marco Bonavia, Luisa Brussino, Caterina Bucca, Marco Caminati, Giorgio Walter Canonica, et al. 2020. “The Importance of Being Not Significant: Blood Eosinophils and Clinical Responses Do Not Correlate in Severe Asthma Patients Treated with Mepolizumab in Real Life.” Allergy 75 (6): 1460–63. doi:10.1111/all.14135.